NM_015080.4:c.3758-1228C>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015080.4(NRXN2):​c.3758-1228C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.508 in 152,028 control chromosomes in the GnomAD database, including 23,502 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 23502 hom., cov: 31)

Consequence

NRXN2
NM_015080.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.321

Publications

3 publications found
Variant links:
Genes affected
NRXN2 (HGNC:8009): (neurexin 2) This gene encodes a member of the neurexin gene family. The products of these genes function as cell adhesion molecules and receptors in the vertebrate nervous system. These genes utilize two promoters. The majority of transcripts are produced from the upstream promoter and encode alpha-neurexin isoforms while a smaller number of transcripts are produced from the downstream promoter and encode beta-neuresin isoforms. The alpha-neurexins contain epidermal growth factor-like (EGF-like) sequences and laminin G domains, and have been shown to interact with neurexophilins. The beta-neurexins lack EGF-like sequences and contain fewer laminin G domains than alpha-neurexins. Alternative splicing and the use of alternative promoters may generate thousands of transcript variants (PMID: 12036300, PMID: 11944992).[provided by RefSeq, Jun 2010]
NRXN2 Gene-Disease associations (from GenCC):
  • autism
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.692 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015080.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRXN2
NM_015080.4
MANE Select
c.3758-1228C>G
intron
N/ANP_055895.1
NRXN2
NM_138732.3
c.3637+2622C>G
intron
N/ANP_620060.1
NRXN2
NM_001376262.1
c.3758-1228C>G
intron
N/ANP_001363191.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRXN2
ENST00000265459.11
TSL:5 MANE Select
c.3758-1228C>G
intron
N/AENSP00000265459.5
NRXN2
ENST00000704782.1
c.3767-1228C>G
intron
N/AENSP00000516031.1
NRXN2
ENST00000377559.7
TSL:1
c.3637+2622C>G
intron
N/AENSP00000366782.3

Frequencies

GnomAD3 genomes
AF:
0.509
AC:
77286
AN:
151910
Hom.:
23506
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.186
Gnomad AMI
AF:
0.840
Gnomad AMR
AF:
0.499
Gnomad ASJ
AF:
0.681
Gnomad EAS
AF:
0.227
Gnomad SAS
AF:
0.581
Gnomad FIN
AF:
0.576
Gnomad MID
AF:
0.646
Gnomad NFE
AF:
0.698
Gnomad OTH
AF:
0.552
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.508
AC:
77289
AN:
152028
Hom.:
23502
Cov.:
31
AF XY:
0.502
AC XY:
37328
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.186
AC:
7706
AN:
41462
American (AMR)
AF:
0.499
AC:
7629
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.681
AC:
2363
AN:
3470
East Asian (EAS)
AF:
0.227
AC:
1172
AN:
5168
South Asian (SAS)
AF:
0.581
AC:
2798
AN:
4816
European-Finnish (FIN)
AF:
0.576
AC:
6087
AN:
10564
Middle Eastern (MID)
AF:
0.653
AC:
192
AN:
294
European-Non Finnish (NFE)
AF:
0.698
AC:
47408
AN:
67954
Other (OTH)
AF:
0.554
AC:
1168
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1552
3104
4655
6207
7759
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
662
1324
1986
2648
3310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.597
Hom.:
3714
Bravo
AF:
0.488
Asia WGS
AF:
0.385
AC:
1341
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
5.0
DANN
Benign
0.67
PhyloP100
0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10792443; hg19: chr11-64395252; API